Dementia in Germany: Epidemiology and Prevention Potential
- PMID: 37226316
- PMCID: PMC10487668
- DOI: 10.3238/arztebl.m2023.0100
Dementia in Germany: Epidemiology and Prevention Potential
Abstract
Background: The further development of public-health approaches for the prevention of dementia requires estimates of the number of people with dementia, trends in incidence and prevalence, and the potential impact of preventive measures.
Methods: The projections described here are based on incidence and prevalence data for Europe and on current and projected population figures from the German Federal Statistical Office. Four scenarios were calculated on the basis of two different population projections and the assumption of either stable or declining prevalence. Data from the German Aging Survey were used to estimate the prevention potential for eleven potentially modifiable risk factors for dementia. Weighting factors were determined to adjust for correlations between risk factors.
Results: Approximately 1.8 million people were living with dementia in Germany as of December 31, 2021; the number of new dementia cases in 2021 is estimated at 360 000 to 440 000. In 2033, depending on the scenario, 1.65 to 2 million people aged 65 and older may be affected; we consider likelihood of the lower end of this range to be very low. It is estimated that 38% of these cases are associated with 11 potentially modifiable risk factors. A 15% reduction in the prevalence of risk factors could potentially decrease the number of cases by up to 138 000 in 2033.
Conclusion: We assume that the number of people with dementia in Germany will increase, but there is considerable prevention potential. Multimodal prevention approaches to promote healthy aging should be further developed and put into practice. Better data are needed on incidence and prevalence of dementia in Germany.
Figures

Similar articles
-
Potential of prevention strategies for the modifiable risk factor type 2 diabetes with relation to the future number of dementia patients in Germany- a multi-state projection through 2040.BMC Neurol. 2022 Apr 26;22(1):157. doi: 10.1186/s12883-022-02682-6. BMC Neurol. 2022. PMID: 35468764 Free PMC article.
-
Future number of people with diagnosed type 1 diabetes in Germany until 2040: an analysis based on claims data.BMJ Open Diabetes Res Care. 2023 Apr;11(2):e003156. doi: 10.1136/bmjdrc-2022-003156. BMJ Open Diabetes Res Care. 2023. PMID: 37024151 Free PMC article.
-
Age- and time-dependent model of the prevalence of non-communicable diseases and application to dementia in Germany.Theor Popul Biol. 2014 Mar;92:62-8. doi: 10.1016/j.tpb.2013.11.006. Epub 2013 Dec 10. Theor Popul Biol. 2014. PMID: 24333220
-
Can dementia be prevented? Brain aging in a population-based context.Annu Rev Public Health. 2004;25:1-24. doi: 10.1146/annurev.publhealth.25.101802.122951. Annu Rev Public Health. 2004. PMID: 15015910 Review.
-
[Is it possible to reduce the prevalence of dementia? New approaches are needed to deal with dementia].Semergen. 2018 Nov-Dec;44(8):586-589. doi: 10.1016/j.semerg.2018.07.002. Epub 2018 Oct 15. Semergen. 2018. PMID: 30337147 Review. Spanish.
Cited by
-
Health in old age - status quo, challenges, and opportunities.J Health Monit. 2023 Sep 20;8(3):3-6. doi: 10.25646/11668. eCollection 2023 Sep. J Health Monit. 2023. PMID: 37829117 Free PMC article. No abstract available.
-
What influences life expectancy in people with dementia? Social support as an emerging protective factor.Age Ageing. 2024 Mar 1;53(3):afae044. doi: 10.1093/ageing/afae044. Age Ageing. 2024. PMID: 38497234 Free PMC article.
-
Adherence to a lifestyle intervention - just a question of self-efficacy? Analysis of the AgeWell.de-intervention against cognitive decline.Alzheimers Res Ther. 2024 Jun 22;16(1):133. doi: 10.1186/s13195-024-01499-4. Alzheimers Res Ther. 2024. PMID: 38909256 Free PMC article. Clinical Trial.
-
Dietary changes following a lifestyle-based intervention for dementia risk reduction - results from the AgeWell.de study.Eur J Nutr. 2024 Dec 30;64(1):58. doi: 10.1007/s00394-024-03563-z. Eur J Nutr. 2024. PMID: 39738893 Free PMC article. Clinical Trial.
-
How do patients, medical assistants and physicians accept and experience tablet-based cognitive testing by medical assistants in general practice? - A qualitative study.BMC Prim Care. 2025 May 17;26(1):174. doi: 10.1186/s12875-025-02823-z. BMC Prim Care. 2025. PMID: 40382582 Free PMC article.
References
-
- BMFSFJ, BMG. Berlin: 2020. Nationale Demenzstrategie.
-
- Michalowsky B, Kaczynski A, Hoffmann W. Ökonomische und gesellschaftliche Herausforderungen der Demenz in Deutschland - Eine Metaanalyse. Bundesgesundheitsblatt. 2019;62:981–992. - PubMed
-
- Wu Y-T, Beiser AS, Breteler M, et al. The changing prevalence and incidence of dementia over time—current evidence. Nat Rev Neurol. 20171;3:327–339. - PubMed
-
- Nerius M, Ziegler U, Doblhammer G, Fink A. Trends in der Prävalenz von Demenz und Parkinson-Eine Analyse auf Basis aller gesetzlich versicherten Personen im Alter 65+ in Deutschland zwischen 2009 und 2012. Das Gesundheitswesen. 2020;82:761–769. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical